Recent news on Kytril

Carbon OKs action over prescriptions  -  25 May 2007
Allentown Morning Call,The allegedly overpriced drugs named in the lawsuit are Zofran injections and tablets and Kytril injections and tablets, all of which are used to prevent

UPDATE 1-Barr Pharma unit gets tentative OK for Kytril tablets  -  18 Jan 2007
ReutersVX: Quote, Profile , Research) Kytril tablets, and its shares rose nearly 4 percent. The company expects to receive final approval from the US Food and Drug

Rheologics Establishes Scientific Advisory Board  -  Dec 7, 2006
Genetic Engineering News (press release),...number of capacities in sales (RMA), product management (Tagamet(R), Hycamtin(R)) and new product development (Kytril(R), Androderm(R), Argatroban(R)).

Rheologics Establishes Scientific Advisory Board  -  Dec 7, 2006
Market Wire (press release)...product management (Tagamet®, Hycamtin®) and new product development (Kytril®, Androderm®, Argatroban®). Prior to joining the pharmaceutical industry,

Speaking of generics  Oct 25, 2006
Fosamax, Feb. 2008. Geodon, Sept. 2007. Glyset, July 2009. Imitrex, June 2007. Kytril, June 2008. Lamictal, Jan. 2009. Lotrel, Jan. 2007. Mavik, Dec. 2007. ... -Monterey County Herald, Publicado: Sab Oct 14, 2006 5:01 pm Asunto: Unless directed to do ...  Oct 14, 2006
My grandmother and my aunt are herbalists and kytril y mom dabbled in it, so Id grown up learning about the prope l ties of different herbs, and Id done some ... -Shell Security, Enzo Biochem Appoints Gary C. Cupit, Former Novartis ...  Oct 16, 2006
Pharmaceuticals in a number of sales capacities (RMA), product management (Tagamet®, Hycamtin®) and new product development (Kytril®, Androderm®, Argatroban ... -Business Wire (press release), Enzo Biochem Appoints Gary C. Cupit, Former Novartis ...  Oct 16, 2006
Beecham Pharmaceuticals in a number of sales capacities (RMA), product management (Tagamet(R), Hycamtin(R)) and new product development (Kytril(R), Androderm(R ... -PharmaLive.com (press release), Med firm to refund $70M in overcharges  Sep 12, 2006
Between 1 million and 5 million cancer patients nationwide who used the drugs Kytril and Zofran since 1991 will potentially be eligible for refunds, said Renee ... -MetroWest Daily News

BUSINESS BRIEFS: BRIEFS  Sep 12, 2006
Glaxo engaged in a scheme to inflate the price of Zofran and Kytril for the Medicare and Medicaid programs, which reimburse health care providers based on the ... -Asbury Park Press

Glaxo SmithKline settles pricing case  Sep 15, 2006
The conduct at issue concerned Glaxo’s reporting of wholesale price data for two of its drugs, Kytril and Zofran, injectable anti-nausea drugs used in ... -Nashua Telegraph (subscription)

New Jersey : New Jersey Receives Medicaid Fraud Civil Settlement ...  Sep 12, 2006
...initiated when a federal false claims lawsuit was filed alleging that Glaxo SmithKline inflated the average wholesale price for Zofran and Kytril, which are ... -All American Patriots

Mo. receives $235,757 Medicaid fraud settlement from ...  Sep 1, 2006
...federal government, resolved concerns that GSK improperly inflated the prices it reported that drug purchasers paid for the injectable drugs Kytril and Zofran ... -Bizjournals.com

hw2;Settlement reached with drug maker  Sep 2, 2006
GlaxoSmithKline was alleged to have improperly inflated the average wholesale price for Kytril and Zofran, two injectible anti-nausea drugs used in connection ... -BurlingtonFreePress.com

Former Chiron Exec Joins APT Pharmaceuticals as CEO  Sep 6, 2006
He has played important roles in the development and approval of numerous drugs including Kytril(R), Requip(R), Kredex(R), Paxil CR(R), Cathflo(R) Activase(R ... -Business Wire

Rheologics Establishes Scientific Advisory Board  -  Dec 7, 2006
Genetic Engineering News (press release),...number of capacities in sales (RMA), product management (Tagamet(R), Hycamtin(R)) and new product development (Kytril(R), Androderm(R), Argatroban(R)).

Rheologics Establishes Scientific Advisory Board  -  Dec 7, 2006
Market Wire (press release)...product management (Tagamet®, Hycamtin®) and new product development (Kytril®, Androderm®, Argatroban®). Prior to joining the pharmaceutical industry,

Ohio to get $541K in settlement with GlaxoSmithKline  Aug 15, 2006
According to government allegations, Glaxo increased the reported prices for two anti-nausea drugs used in connection with chemotherapy, Kytril and Zofran, to ... -Charlotte Business Journal

GlaxoSmithKline settles overcharging case for $70 million  Aug 10, 2006
The case was settled for patients on two GSK drugs, Kytril and Zofran. The drugs are commonly used to counter the side effects of cancer treatments. ... -Raw Story

Prescription Drugs | GlaxoSmithKline To Pay $70M To Settle ...  Aug 11, 2006
The settlement pertains to injectable antinausea drugs Kytril and Zofran, which are given to cancer patients undergoing chemotherapy, as well as to the ... -Kaiser network.org

GlaxoSmithKline settles $91m suit  Aug 10, 2006
...settlement will provide restitution to consumers who suffered from a "decade-long company scheme to inflate the price of two cancer drugs", Zofran and Kytril. ... -The Australian

Landmark Settlement Could Signal the End of Prescription Drug ...  Aug 10, 2006
...will pay $70 million in a nationwide class-action settlement to cancer patients and health plans who were overcharged for vital medications Kytril and Zofran. ... -U.S. Newswire

GlaxoSmithKline to Pay $70 Million to End Drug Suits (Update3)  Aug 10, 2006
...health program for the elderly and disabled, has moved away from AWP-linked payments for drugs administered in doctors offices, such Glaxo's Kytril and Zofran ... -Bloomberg

Attorney General: Kan. to Receive $58,065 in Glaxo SmithKline ...  Aug 17, 2006
...issue concerned Glaxo's reporting of bench mark pricing data that was used by Medicare and Medicaid to set reimbursement amounts for its drugs Kytril and Zofran ... -Insurance Journal

GlaxoSmithKline in US cancer drug settlement  Aug 10, 2006
Connecticut, New York, Nevada, Montana and Arizona who suffered from a "decade long company scheme to inflate the price of two cancer drugs," Zofran and Kytril ... -Reuters

GlaxoSmithKline to Pay $70 Million to End Drug Suits (Update1)  Aug 10, 2006
New York's Medicaid program will get $1.5 million as restitution for inflated prices for two chemotherapy drugs, Kytril and Zofran, and an antibiotic, Amoxil. ... -Bloomberg

Glaxo pays $70m to end price row  Aug 10, 2006
The lawsuits stem from claims that Glaxo used illegal schemes to inflate the price of drugs - including cancer treatments Zofran and Kytril - costing consumers ... -BBC News

Glaxo will settle suits by paying $70 million  Aug 11, 2006
New York's Medicaid program will get $1.5 million as restitution for inflated prices of Kytril and Zofran, injectable antinausea drugs used in connection with ... -Philadelphia Inquirer

Glaxo Settles on Illegal Drug Pricing Charge  Aug 11, 2006
...that the Research Triangle, NC-based company had essentially indicated to doctors and hospitals that it was willing to supply its drugs, Kytril and Zofran, for ... -Brandweek Magazine

GlaxoSmithKline Settles Illegal Pricing Scheme  Aug 11, 2006
GSK will pay the New York Medicaid program a total of $1.53 million in restitution for inflating the prices of three specific drugs -- Kytril and Zofran ... -Consumer Affairs

Health Canada Warns About Possible Cardiac Complications With ...  Jul 4, 2006
Health Canada is requesting all manufacturers of the drugs in this class (5-HT3 antagonists, Anzemet®, Kytril®, and Zofran®) to conduct thorough analyses of ... -DG News

Aranesp® Will Not Be Classified as Equal to Procrit® by Medicare  Jun 30, 2006
This new methodology will have lower payment rates for numerous drugs, such as Taxol®, Aredia® and Kytril®--drugs that contribute to the highest ... -Cancer Consultants



Novacea Appoints Amar Singh as Chief Commercialization Officer  Mar 15, 2006
...where he led the launches of XELODA®, a novel oral chemotherapeutic agent for the treatment of metastatic breast cancer, and KYTRIL®, an anti-nausea agent ... - Market Wire

MP-Technopharma to Start Contract Manufacturing of Chugai ...  Mar 22, 2006
Capsule" well as ACE Inhibitor "Inhibace® Tablet", antiParkinsonism drug "Madopar® Tablet" and 5-HT3 receptor antagonist antinauseant "Kytril® Granule". ... - PharmaLive.com

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional